SmallCapReview.com has been a leading site for information on small cap stocks, penny stocks and microcaps since 1999, to receive the free SmallCapReview newsletter visit http://www.smallcapreview.com/.
Immucor, Inc. (Nasdaq: BLUD) $21.44. Today announced that its fourth generation automated instrument, NEO, has been cleared for marketing in the U.S. by the
"We believe there is a significant market opportunity for NEO and we are very excited about achieving 510(k) clearance from the FDA," stated Dr. Gioacchino De Chirico, Immucor's President and Chief Executive Officer. "NEO is the most recent example of Immucor's commitment to deliver products that improve patient safety and the practice of transfusion medicine."
Immucor's innovative automation strategy provides scalable solutions to meet the needs of all blood banks, regardless of size. Immucor has continually invested in automation since 1998, most recently with NEO. Immucor's fourth generation automated instrument, NEO is designed to increase productivity, performance and flexibility of high volume laboratories. NEO delivers the market's highest type-and-screen throughput and broadest test menu as well as new STAT priority functionality for improved workflow.
What They Do: Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion.
Regency Energy Partners LP (Nasdaq: RGNC) $22.97. Today announced that it has acquired approximately 7.0% of the Haynesville Joint Venture from an affiliate of GE Energy Financial Services, a unit of GE (NYSE: GE), for approximately $92 million and the right to vote the interest retained by GE Energy Financial Services. Regency’s total ownership interest in the Joint Venture is now approximately 49.99%. Regency will continue as operator of the Regency Intrastate Gas System, which transports gas from the Haynesville Shale, one of the fastest growing U.S. natural gas fields.
Alinda Capital Partners LLC (“Alinda”), an independent private investment firm specializing in infrastructure investments, will retain its 50% ownership interest in the Haynesville Joint Venture.
“Increasing our ownership of the Haynesville Joint Venture is in line with our long-term growth strategy of increasing fee-based assets, which generate stable cash flows,” said Byron Kelley, chairman, president and chief executive officer of Regency.
The transaction, funded using Regency’s revolving credit facility, is expected to be immediately accretive to cash available for distribution.
What They Do: Regency Energy Partners LP is a growth-oriented, midstream energy partnership engaged in the gathering, contract compression, processing, marketing and transporting of natural gas and natural gas liquids.
Dendreon Corporation (Nasdaq: DNDN) $50.18. Today announced that the
The FDA approval of PROVENGE is a testament to the courage of the patients and researchers who participated in our studies and is the culmination of nearly 15 years of research and development by our dedicated employees," said Mitchell H. Gold, M.D., president and chief executive officer of Dendreon. "The approval of PROVENGE is a significant step towards realizing our mission of transforming the lives of patients with cancer, and it also marks Dendreon's transformation into a commercial enterprise, ready to support the successful launch of the first personalized treatment for cancer."
What They Do: Dendreon Corporation is a biotechnology company targeting cancer and transforming lives through the discovery, development, commercialization and manufacturing of novel therapeutics.
About SmallCapReview
Copyright SmallCapReview. SmallCapReview.com is a leading site for news on small-caps, penny stocks and microcaps. SmallCapReview has built a loyal opt-in following for their investor products by providing a newsletter at no cost, sent to subscribers, highlighting select stocks in play, to register visit http://www.smallcapreview.com/. To follow us on Twitter visit http://twitter.com/SmallCapReview.
